254 related articles for article (PubMed ID: 31199813)
1. Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
Li Y; Li M; Shats I; Krahn JM; Flake GP; Umbach DM; Li X; Li L
PLoS One; 2019; 14(6):e0218067. PubMed ID: 31199813
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
Lohcharoenkal W; Das Mahapatra K; Pasquali L; Crudden C; Kular L; Akkaya Ulum YZ; Zhang L; Xu Landén N; Girnita L; Jagodic M; Ståhle M; Sonkoly E; Pivarcsi A
J Invest Dermatol; 2018 Apr; 138(4):882-892. PubMed ID: 29104160
[TBL] [Abstract][Full Text] [Related]
3. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
[TBL] [Abstract][Full Text] [Related]
4. Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
Kitago M; Martinez SR; Nakamura T; Sim MS; Hoon DS
Clin Cancer Res; 2009 May; 15(9):2988-94. PubMed ID: 19336521
[TBL] [Abstract][Full Text] [Related]
5. Identifying
Liu XT; Liu TT; Wu MY; Chen QX; Zhuang JX; Wang Q
Genet Test Mol Biomarkers; 2021 Jan; 25(1):68-78. PubMed ID: 33470885
[No Abstract] [Full Text] [Related]
6. Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma.
Zhao CC; Guo H; Wang Y; Li JH
Hum Cell; 2021 Mar; 34(2):654-666. PubMed ID: 33400243
[TBL] [Abstract][Full Text] [Related]
7. Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma.
Barbato A; Iuliano A; Volpe M; D'Alterio R; Brillante S; Massa F; De Cegli R; Carrella S; Salati M; Russo A; Russo G; Riccardo S; Cacchiarelli D; Capone M; Madonna G; Ascierto PA; Franco B; Indrieri A; Carotenuto P
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670365
[TBL] [Abstract][Full Text] [Related]
8. miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.
Fu Y; Sun LQ; Huang Y; Quan J; Hu X; Tang D; Kang R; Li N; Fan XG
Curr Mol Med; 2018; 18(3):135-141. PubMed ID: 30198432
[TBL] [Abstract][Full Text] [Related]
9. Prediction and Analysis of Skin Cancer Progression using Genomics Profiles of Patients.
Bhalla S; Kaur H; Dhall A; Raghava GPS
Sci Rep; 2019 Oct; 9(1):15790. PubMed ID: 31673075
[TBL] [Abstract][Full Text] [Related]
10. Toward predicting metastatic progression of melanoma based on gene expression data.
Li Y; Krahn JM; Flake GP; Umbach DM; Li L
Pigment Cell Melanoma Res; 2015 Jul; 28(4):453-63. PubMed ID: 25847062
[TBL] [Abstract][Full Text] [Related]
11. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
Zhu Y; Wen X; Zhao P
Med Sci Monit; 2018 Jun; 24():3679-3692. PubMed ID: 29858490
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Mueller DW; Bosserhoff AK
Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
[TBL] [Abstract][Full Text] [Related]
14. Analysis of melanoma-related microRNAs expression during the spontaneous regression of cutaneous melanomas in MeLiM pigs.
Baco M; Chu CY; Bouet S; Rogel-Gaillard C; Bourneuf E; Le Provost F; Chu CY; Vincent-Naulleau S
Pigment Cell Melanoma Res; 2014 Jul; 27(4):668-70. PubMed ID: 24661544
[No Abstract] [Full Text] [Related]
15. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
[TBL] [Abstract][Full Text] [Related]
16. Combined miRNA profiling and proteomics demonstrates that different miRNAs target a common set of proteins to promote colorectal cancer metastasis.
Torres S; Garcia-Palmero I; Bartolomé RA; Fernandez-Aceñero MJ; Molina E; Calviño E; Segura MF; Casal JI
J Pathol; 2017 May; 242(1):39-51. PubMed ID: 28054337
[TBL] [Abstract][Full Text] [Related]
17. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
[TBL] [Abstract][Full Text] [Related]
18. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
[TBL] [Abstract][Full Text] [Related]
19. Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression.
Sun Z; Zhou S; Tang J; Ye T; Li J; Liu D; Zhou J; Wang J; Rosie Xing H
EBioMedicine; 2018 Nov; 37():47-55. PubMed ID: 30301603
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
Shi L; Huo JW; Chen SS; Xue JX; Gao WY; Li XY; Song YH; Xu HT; Zhu XW; Chen K
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5332-5342. PubMed ID: 31298385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
